Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 196,542 | 59,606 | 3,686 | 0 | 0 |
| Cost of Goods | 19,128 | 4,987 | 754 | N/A | N/A |
| Gross Profit | 177,414 | 54,619 | 2,932 | N/A | N/A |
| Operating Expenses | 305,939 | 296,707 | 305,313 | 206,529 | 136,645 |
| Operating Income | -128,397 | -241,101 | -301,627 | -206,529 | -136,645 |
| Interest Expense | 27,168 | 29,712 | 15,652 | 0 | 0 |
| Other Income | 16,173 | 11,786 | 5,821 | 173 | 967 |
| Pre-tax Income | -139,392 | -259,027 | -311,458 | -206,356 | -135,678 |
| Income Tax | 647 | 3,113 | N/A | N/A | N/A |
| Net Income Continuous | -140,039 | -262,140 | -311,458 | -206,356 | -135,678 |
| Net Income | $-140,039 | $-262,140 | $-311,458 | $-206,356 | $-135,678 |
| EPS Basic Total Ops | -1.16 | -3.78 | -5.66 | -4.18 | -3.80 |
| EPS Basic Continuous Ops | -1.16 | -3.78 | -5.66 | -4.18 | -3.80 |
| EPS Diluted Total Ops | -1.16 | -3.78 | -5.66 | -4.18 | -3.80 |
| EPS Diluted Continuous Ops | -1.16 | -3.78 | -5.66 | -4.18 | -3.80 |
| EPS Diluted Before Non-Recurring Items | -1.16 | -3.78 | -5.66 | -4.18 | -3.80 |
| EBITDA(a) | $-132,699 | $-246,569 | $-302,946 | $-202,621 | $-136,451 |